SCHEMBL63327

SCHEMBL63327

CC[C@@H]1CO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1067947 1.00 ALDH1A1 (0.46)
SCHEMBL50501 1.00
SCHEMBL64078 1.00
SCHEMBL20049438 0.96 ALDH1A1 (0.43)
SCHEMBL12514606 0.96 ALDH1A1 (0.43)
SCHEMBL6577965 0.96
Ammonia Solution, Strong SCHEMBL11738986 0.96
SCHEMBL9491437 0.96
Hydrochloric Acid SCHEMBL28301599 0.96
SCHEMBL26784069 0.96 ALDH1A1 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 422 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1518850-B1 Enantiomer-enriched 2-butanol LANXESS DEUTSCHLAND GMBH (DE) 2007-06-20 EP claimed
US-6960680-B2 Manufacture of water-soluble β-hydroxynitriles RHODIA CHIREX, INC. (US) 2005-11-01 US claimed
EP-1518850-A1 Enantiomer-enriched 2-butanol Bayer Chemicals AG (DE) 2005-03-30 EP claimed
US-20050054736-A1 Enantiomerically enriched 1,2-epoxybutane is reduced with hydrogen in the presence of palladium and/or palladium compounds and a vicinal diamine; provides a highly regioselective epoxide opening which proceeds without racemization LANXESS DEUTSCHLAND GMBH (DE) 2005-03-10 US claimed
CN-122079853-A N-substituted indoles and other heterocyclic compounds for the treatment of brain diseases 2026-05-26 CN disclosed
EP-4688778-A1 1H-PYRROLO[2,3-B]PYRIDIN-4-YL]-2-OXOPYRROLIDINE-3-CARBONITRILE DERIVATIVES AS TYROSINE KINASE 2 (TYK2) INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES Biogen MA Inc. (US) 2026-02-11 EP disclosed
US-12540157-B2 Oxysterols and methods of use thereof Sage Therapeutics, LLC (US) 2026-02-03 US disclosed
US-20250353864-A1 INDAZOLE CONTAINING MACROCYCLES AND THEIR USE BLOSSOMHILL THERAPEUTICS INC (US) 2025-11-20 US disclosed
US-20250326770-A1 BENZOTRIAZOLE COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2025-10-23 US disclosed
US-20250313573-A1 HYDROXYPYRIDOXAZEPINES AS NRF2 ACTIVATORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2025-10-09 US disclosed
US-20250296939-A1 BENZOTHIOPHENE COMPOUND KYOTO PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2025-09-25 US disclosed
US-20250282724-A1 BENZOTRIAZOLE COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2025-09-11 US disclosed
US-20040054201-A1 Chiral polymeric salen catalyst, and a process for preparing chiral compounds from racemic epoxides by using them RSTECH CO., LTD. (KR) 2004-03-18 US disclosed
WO-2003055478-A1 GLYT1 TRANSPORTER INHIBITORS AND USES THEREOF IN TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS SMITHKLINE BEECHAM P.L.C. (GB) 2003-07-10 WO disclosed
EP-1289655-A1 NOVEL CHIRAL SALEN CATALYSTS, AND A PROCESS FOR PREPARING CHIRAL COMPOUNDS FROM RACEMIC EPOXIDES FOR USING THEM Rstech Co., Ltd. (KR) 2003-03-12 EP disclosed
US-20030032821-A1 Novel chiral salen catalysts, and a process for preparing chiral compounds from racemic epoxides for using them RSTECH CO., LTD. (KR) 2003-02-13 US disclosed
WO-2002048162-A1 CHIRAL POLYMERIC SALEN CATALYST, AND A PROCESS FOR PREPARING CHIRAL COMPOUNDS FROM RACEMIC EPOXIDES BY USING THEM RSTECH CO., LTD (KR) 2002-06-20 WO disclosed
WO-2001089690-A1 NOVEL CHIRAL SALEN CATALYSTS, AND A PROCESS FOR PREPARING CHIRAL COMPOUNDS FROM RACEMIC EPOXIDES FOR USING THEM RSTECH CO., LTD. (KR) 2001-11-29 WO disclosed
US-20010031710-A1 Optically active, oxygenated, alicyclic compounds and their use as perfuming ingredients FIRMENICH SA (CH) 2001-10-18 US disclosed
EP-1136061-A2 Optically active, oxygenated, alicyclic compounds and their use as perfuming ingredients FIRMENICH SA (CH) 2001-09-26 EP disclosed